RF Acquisition Corp III is no longer hunting. The vehicle signed a definitive combination in early July that would take HCC Healthcare, a Singapore holdco for a Taiwan medical and long-term care network, onto a United States listing. The search option that the winter offering sold has been replaced by a deal-credibility question: whether the target's affiliated bed count survives the registration statement as owned economics rather than a marketing perimeter.
The ordinary shares still trade like a cash stub. Trust cash at the latest balance sheet sat at $101.3 million. That works out to a redemption value a bit above the original unit price on each public share, and the tape has recently printed a modest discount to that floor. Net income for the latest quarter was $0.57 million, a noncash figure driven by trust interest rather than any operating franchise. General costs jumped in the latest quarter as counsel and deal work replaced the quiet search months. None of that income is distributable, and none of the cost is the target's operating story.
What remains unresolved is the registration. The combination agreement points to a foreign-issuer registration statement, a shareholder vote, an exchange listing of the target's shares, and an outside date measured in months rather than years. Those documents are not yet on the public docket as of this report. Until they arrive, the equity is a near-par claim on cash plus an unpriced call on a Taiwan care platform whose scale is described on a pro forma affiliated basis. Does the coming registration convert that call into a business an owner can underwrite, or does it leave a trust floor and a marketing brochure?